The 2022 OncoAlert Colloquium Day 1: Breast Cancer

Latest in lung cancer genomic testing

Kinetics of postop circulating cell-free DNA and impact on MRD detection rates in resected stage I-III colorectal cancer

ASH 2022: Multiple myeloma roundup

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML

Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery

Breast cancer in elderly patients: a clinicopathological review of a Nigerian database

HER2DX confirms the ability of the test to predict long-term survival and response to anti-HER2 therapy in BC

Challenges and opportunities of integrative oncology as an effective tool to enhance cancer prevention and treatment in LMICs.

Monitoring and evaluation as a tool for quality improvement in cancer screening

Initiatives in monitoring of cancer screening in low- and middle-income countries

Systemic anti-cancer performance matrix